| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0069 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.015 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |